27 November 2025
Home > News & Resources > Budget 2025
27 November 2025
3 min read
A look at what the 2025 Budget means for innovative businesses: more public money flowing into R&D, a new advance assurance service for SMEs, clearer rules around credits, and updated investment schemes for scaling companies. We break down how these changes will play out day to day, especially as HMRC moves towards a more structured, scrutiny-led approach to R&D claims.
In a Budget that raised both taxes and spending (and was published 45 minutes before the Chancellor stood up in the Commons ) there will be more public funding in the system for innovation, more incentives for scaling companies, but also more scrutiny and structure around R&D tax claims.
Public R&D funding is increasing significantly in the coming years. Annual government investment will rise to £22.6 billion by 2029-30.
UKRI will direct £9 billion of that into key growth sectors, including £4.5 billion for innovative UK companies.
This sits alongside:
We have clear political commitment to R&D and innovation. We might also have an evolving HMRC expectation that claims will align more clearly with recognised Government innovation priorities.
The key tax development is the introduction of a targeted advance assurance service for SMEs, launching in spring 2026.
HMRC will let smaller companies get clarity on eligibility before they submit a claim. On paper, this reduces disputes and uncertainty.
In practice, it also formalises the expectation of transparency up front. For accountants, advisory conversations are likely to shift from “let’s claim and see what happens” to “let’s agree the boundary first”.
There’s also a subtle administrative update: the corporation tax treatment of intra-group payments related to RDEC and creative sector expenditure credits is being clarified. This applies from 26 November 2025.
It won’t affect everyone, but for businesses using surrenderable credits, it’s worth noting.
A few changes outside the R&D scheme will indirectly affect innovative scale-ups:
For companies struggling to raise capital because they’ve “outgrown” existing schemes, the change matters.
We’re all well aware of HMRC’s increasing scrutiny of claims. This Budget continues that trajectory, but adds structure and predictability.
The practical implications are:
For businesses who treat R&D relief as an annual tax optimisation exercise rather than a strategic innovation tool, now’s the time to review that approach.
There’s more support for innovation than ever, but the government – of course – wants value for money and measurable outcomes.
We await news of any outcomes from the R&D tax relief advance clearances consultation (voluntary and mandatory clearances, minimum expenditures thresholds) and perhaps look forward to a more stable and predictable landscape for R&D tax relief – at least in the short term.